A new trading day began on Tuesday, with Kura Oncology Inc (NASDAQ: KURA) stock price down -1.92% from the previous day of trading, before settling in for the closing price of $10.96. KURA’s price has ranged from $9.06 to $24.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -14.68%. With a float of $65.06 million, this company’s outstanding shares have now reached $74.35 million.
Let’s look at the performance matrix of the company that is accounted for 142 employees. In terms of profitability, gross margin is 48.82%, operating margin of -12410.87%, and the pretax margin is -15555.28%.
Kura Oncology Inc (KURA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kura Oncology Inc is 16.33%, while institutional ownership is 91.87%. The most recent insider transaction that took place on Nov 18 ’24, was worth 8,434. In this transaction Chief Operating Officer of this company sold 526 shares at a rate of $16.03, taking the stock ownership to the 23,184 shares. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 526 for $15.99, making the entire transaction worth $8,410.
Kura Oncology Inc (KURA) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.55 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Here are Kura Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -2.07 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Kura Oncology Inc (NASDAQ: KURA) saw its 5-day average volume 6.48 million, a positive change from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 12.68%. Additionally, its Average True Range was 1.20.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 7.75%, which indicates a significant decrease from 10.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 192.79% in the past 14 days, which was higher than the 82.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.49, while its 200-day Moving Average is $19.84. Nevertheless, the first resistance level for the watch stands at $10.99 in the near term. At $11.23, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.46. If the price goes on to break the first support level at $10.52, it is likely to go to the next support level at $10.29. The third support level lies at $10.05 if the price breaches the second support level.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
With a market capitalization of 835.96 million, the company has a total of 77,764K Shares Outstanding. Currently, annual sales are 0 K while annual income is -152,630 K. The company’s previous quarter sales were 0 K while its latest quarter income was -54,400 K.
